Rxo (RXO) Cash from Operations (2021 - 2026)

Rxo (RXO) has reported Cash from Operations for 6 consecutive years, with -$40.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 273.91% year-over-year to -$40.0 million; the trailing twelve-month figure through Jun 2026 stood at -$17.0 million (down 342.86% YoY), and the FY2025 full-year result was $51.0 million, up 525.0% from the prior year.
• Cash from Operations retreated to -$40.0 million in Q2 2026 per RXO's latest filing, from -$7.0 million in the prior quarter.
• Across five years, Cash from Operations topped out at $103.0 million in Q1 2022 and bottomed at -$40.0 million in Q2 2026.
• Historically, Cash from Operations has averaged $21.7 million across 5 years, with a median of $13.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations slumped 275.0% in 2024, then soared 560.0% in 2025.
• Over 5 years, Cash from Operations stood at $76.0 million in 2022, then plunged by 75.0% to $19.0 million in 2023, then slumped by 136.84% to -$7.0 million in 2024, then jumped by 200.0% to $7.0 million in 2025, then plunged by 671.43% to -$40.0 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$40.0 million, -$7.0 million, and $7.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.